Return to List
Results 1–12 of 12
Title Date
1.

Adolescent Confidentiality and Electronic Health Records

Number 599

Abstract: Confidentiality concerns are heightened during adolescence, and these concerns can be a critical barrier to adolescents in receiving appropriate health care. Health care providers caring fo...

May 2014

PDF Format
2.

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Number 539

(Replaces No. 392, December 2007)

ABSTRACT: Long-acting reversible contraception (LARC)—intrauterine devices and the contraceptive implant—are safe and appropriate contraceptive methods for most women and adolescents. The LARC method...

October 2012

PDF Format
3.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing t...

June 2014

PDF Format
4.

Health Care for Transgender Individuals

Number 512

ABSTRACT: Transgender individuals face harassment, discrimination, and rejection within our society. Lack of awareness, knowledge, and sensitivity in health care communities eventually leads to inade...

December 2011

PDF Format
5.

Human Papillomavirus Vaccination

Number 588

(Replaces Committee Opinion Number 467, September 2010)

ABSTRACT: The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that human papillomavirus (HPV) vaccination routinely be targeted to females an...

March 2014

PDF Format
6.

Menstrual Manipulation for Adolescents With Disabilities

Number 448

(Reaffirmed 2012)

ABSTRACT: Defining the reasons for intervention and the precise goal of treatment are the most critical issues regarding use of interventions to alter menstrual flow in adolescents with disabilities....

December 2009

PDF Format
7.

Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign

Number 349

(Reaffirmed 2009)

ABSTRACT: Young patients and their parents often are unsure about what represents normal menstrual patterns, and clinicians also may be unsure about normal ranges for menstrual cycle length and amoun...

November 2006

PDF Format
8.

Müllerian Agenesis: Diagnosis, Management, and Treatment

Number 562

(Replaces No. 355, December 2006)

ABSTRACT: Müllerian agenesis occurs in 1 out of every 4,000–10,000 females. The most common presentation of müllerian agenesis is congenital absence of the vagina, uterus, or both, which also is refe...

May 2013

PDF Format
9.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT: Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the U.S. correctional system. In...

August 2012

PDF Format
10.

Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills

Number 540

ABSTRACT: Although the risk of venous thromboembolism is increased among oral contraceptive users compared with nonusers who are not pregnant and not taking hormones, and some data have suggested tha...

November 2012

PDF Format
11.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

Abstract: The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years. The initial repro...

May 2014

PDF Format
12.

Von Willebrand Disease in Women

Number 580

(Replaces No. 451, December 2009)

ABSTRACT: Von Willebrand disease, the most common inherited bleeding disorder among American women, is a common cause of heavy menstrual bleeding and other bleeding problems in women and adolescent g...

December 2013

PDF Format